Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT.
The metal binding protein metallothionein (MT) is involved in zinc homeostasis since it typically binds large amounts of zinc. Free zinc can control MT gene expression by interacting with metal-sensitive transcription factors. However, the precise factors governing intracellular release of metal ions from MT remain unknown. Aerobic nitric oxide (NO) can nitrosate thiol groups in proteins, and MT-bound cadmium is released by NO exposure. Thus, we hypothesized that NO may also be effective at displacing zinc from MT in cultured cells and that this could be an important physiological control mechanism in zinc homeostasis and utilization. In this study, DETA/NO, an agent that spontaneously generates NO with a 20-h half life in physiological media, was used to study the release of zinc from MT and the induction of MT in TRL1215 cells (a normal rat liver cell line). Zinc or cadmium was given at levels inducing MT production, followed by DETA/NO (20-200 microM) to produce controlled NO exposure in both cell lines. Although both metals activated MT gene expression, MT-I mRNA and MT protein were further increased when DETA/NO was given after zinc or cadmium treatment. Additionally, NO from DETA/NO clearly displaced MT-bound zinc, as evidenced by G-75 gel-filtration chromatography. The released zinc or cadmium probably then stimulates further MT gene expression. These results suggest that NO may play an important role in regulation of cellular zinc homeostasis by providing a controlled release mechanism for metal ions stored in MT, and NO-mediated release of MT-bound zinc could in turn activate gene expression, such as with the MT gene.
Katakai
K
K
Laboratory of Comparative Carcinogenesis, NCI at NIEHS, Research, Mail Drop F0-09, 111 Alexander Drive, 27709, Research Triangle Park, NC, USA.
Liu
J
J
Nakajima
K
K
Keefer
L K
LK
Waalkes
M P
MP
D000818:Animals; D015870:Gene Expression / Q000187:drug effects*; D006801:Humans; D008668:Metallothionein / Q000235:genetics* / Q000378:metabolism; D009569:Nitric Oxide / Q000494:pharmacology*; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D014226:Triazenes / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D015032:Zinc / Q000378:metabolism*
C105351:1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene; D020030:Nitric Oxide Donors; D012333:RNA, Messenger; D014226:Triazenes; D009569:Nitric Oxide; D008668:Metallothionein; D015032:Zinc